All Posts
Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
13 Apr, 2022 | 10:15h | UTC
M-A: Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV.
13 Apr, 2022 | 10:18h | UTCNews Release: Protease inhibitors safer than thought for pregnant women with HIV – University of Oxford
Brief review | Infective endocarditis: words of caution for management.
13 Apr, 2022 | 10:12h | UTCInfective Endocarditis: Words of Caution For Management – American College of Cardiology
Related:
Randomized Trial: Partial Oral vs. Intravenous Antibiotic Treatment of Endocarditis
Podcast: Infective Endocarditis Pearls.
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
Infective Endocarditis: A Contemporary Review
Summary: Current AATS Guidelines on Surgical Treatment of Infective Endocarditis
Review: Current Evidence on Oral Antibiotics for Infective Endocarditis
Research: Invasive Procedures Associated With the Development of Infective Endocarditis
Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement
Interplay of mineralocorticoid receptor antagonists and Empagliflozin in heart failure: Secondary analysis of the EMPEROR-Reduced trial.
13 Apr, 2022 | 10:14h | UTCEditorial: Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care
RCT: Prophylactic Rivaroxaban for 30 days to prevent left ventricular thrombus after anterior ST-Segment Elevation Myocardial Infarction.
13 Apr, 2022 | 09:56h | UTCProphylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)
Drug resistant TB – latest developments in epidemiology, diagnostics and management.
13 Apr, 2022 | 10:09h | UTCRelated:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment
Canadian Tuberculosis Standards – 8th Edition.
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
New WHO online course: Monkeypox epidemiology, preparedness and response.
13 Apr, 2022 | 10:03h | UTCMonkeypox epidemiology, preparedness and response – OpenWHO
Commentary on Twitter
Monkeypox remains an under-recognized and underreported emerging disease. Good clinical management can limit disease severity or death.
Learn about prevention and control of #monkeypox in our 🆕 free online course on #OpenWHO:
👉 https://t.co/3MtOCbiVoI pic.twitter.com/o1NabpyEzD— World Health Organization (WHO) (@WHO) April 10, 2022
M-A: Three-port vs. four-port technique for laparoscopic cholecystectomy.
13 Apr, 2022 | 10:02h | UTC
Commentary on Twitter
Laparoscopic cholecystectomy: 3 port 🤜🤛 4 port
📚 Syst review meta-analysis of 18 trials
🟰 length procedure and adverse events
⌛️ 3 ports LOS 0.3 days less 🫤📐 Use of 3 ports should not be at the expense of safe dissection of Calot’s trianglehttps://t.co/yumsSJpPFt pic.twitter.com/qgNMQitY0e
— Giovanni Marchegiani (@Gio_Marchegiani) April 9, 2022
Study identifies which treatments are associated with an increased risk of heart disease among women with breast cancer.
13 Apr, 2022 | 10:00h | UTCRisk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Major study links breast cancer treatment with increased risk of cardiovascular disease – Fred Hutch
Commentary on Twitter
Great case-control study in a modern cohort evaluating long-term cardiovascular disease after #breastcancer treatment. HR for heart failure/cardiomyopathy higher for anthracyclines (HR=1.84) and herceptin (HR=2.53) than for #radiotherapy (HR=1.38). #bcsmhttps://t.co/ZEVfbwlepr
— Shane Stecklein, MD, PhD (@shanestecklein) April 8, 2022
Seminar: Cholera.
13 Apr, 2022 | 09:55h | UTCCholera – The Lancet (free registration required)
Review | PCI in patients with heart failure: current evidence, impact of complete revascularization, and contemporary techniques to improve outcomes.
13 Apr, 2022 | 09:57h | UTC
Commentary on Twitter
#PCI in Patients With #HeartFailure: Current Evidence,Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomeshttps://t.co/cMKIByKN7n @GreggWStone @MVMadhavanMD @ericjvelazquez @mmamas1973 @mirvatalasnag @AndrewJSauer @ShelleyZieroth @DrMarthaGulati pic.twitter.com/3A9BWwD7Gc
— Henry Han (@HanCardiomd) April 9, 2022
(Images and article under a CC BY 4.0 Licence)
M-A: Assessment of frequency of rosacea subtypes in patients with rosacea.
13 Apr, 2022 | 09:54h | UTCAssessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis – JAMA Dermatology (link to abstract – $ for full-text)
Commentary: Study Evaluates Prevalence of 4 Major Rosacea Subtypes – HCPLive
Commentary on Twitter
In this systematic review and meta-analysis, erythematotelangiectatic and papulopustular rosacea are the most common subtypes of #rosacea based on global data. https://t.co/2lWCjrIIWP
— JAMA Dermatology (@JAMADerm) April 7, 2022
Systematic Review: Control interventions in randomized trials among people with mental health disorders.
13 Apr, 2022 | 09:38h | UTCFeatured review: Control interventions in randomized trials among people with mental health disorders
Systematic Review: Tacrolimus for induction of remission in corticosteroid‐refractory ulcerative colitis.
13 Apr, 2022 | 09:37h | UTC
Systematic Review: Narrow band imaging vs. white light cystoscopy alone for transurethral resection of non‐muscle invasive bladder cancer.
13 Apr, 2022 | 09:36h | UTC
Cohort Study: Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of the Pfizer vaccine in adolescents.
12 Apr, 2022 | 10:07h | UTC
RCT: Single-dose HPV vaccination found effective among young African women.
12 Apr, 2022 | 10:08h | UTCEfficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence
News Releases:
Study boosts support for single-dose HPV vaccine regimen – University of Washington
Related:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Commentary on Twitter (thread – click for more)
🚨 GAME CHANGER 🚨
One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK pic.twitter.com/ZKDvpf2qog— World Health Organization (WHO) (@WHO) April 11, 2022
M-A: SGLT2 inhibitors reduce hospitalizations in patients with heart failure regardless of the presence of diabetes.
12 Apr, 2022 | 10:05h | UTCSodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: SGLT2 inhibitors reduces hospitalization for heart failure regardless of presence of diabetes – American College of Physicians
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
12 Apr, 2022 | 10:02h | UTC
AHA Scientific Statement: SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults.
12 Apr, 2022 | 09:59h | UTCNews Release: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association
Commentary: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD
Opinion | Aligning incentives for improving diagnostic excellence.
12 Apr, 2022 | 09:54h | UTCAligning Incentives for Improving Diagnostic Excellence – JAMA (free for a limited period)
Cohort Study: Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection.
12 Apr, 2022 | 09:57h | UTCCommentary: Older Kids More Vulnerable to MIS-C: Study – HealthDay
More data suggests the Omicron variant causes milder disease compared to the Delta variant.
12 Apr, 2022 | 09:49h | UTCRelated:
Perspective: Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
[Preprint] SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
RCT: Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer.
12 Apr, 2022 | 08:54h | UTCNeoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer – New England Journal of Medicine
News Release: Immunotherapy Plus Chemotherapy Before Surgery Improves Outcomes for Patients with Lung Cancer – Johns Hopkins Medicine
Commentary on Twitter
In patients with resectable NSCLC, neoadjuvant nivolumab plus chemo results in longer event-free survival and a greater likelihood of pathological complete response than chemo alone. #AACR22 https://t.co/ILjdRZQ7dJ pic.twitter.com/1JfiUw18R6
— NEJM (@NEJM) April 11, 2022
COVID-19 disease severity in children infected with the Omicron variant.
12 Apr, 2022 | 09:47h | UTC
Commentary on Twitter
COVID-19 Disease Severity in Children Infected with Omicron
Among Delta infected
84.2% had mild
15.7% had moderate
0.1% had severe/critical disease
Among Omicron infected
97.8% had mild
2.2% had moderate
None had severe/critical disease (P < .001 https://t.co/ZHhVpY8LuG— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 11, 2022


